Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis

被引:115
作者
Singh, RR
Saxena, V
Zang, S
Li, L
Finkelman, FD
Witte, DP
Jacob, CO
机构
[1] Univ Cincinnati, Coll Med, Vet Affairs Med Ctr, Dept Internal Med, Cincinnati, OH 45220 USA
[2] Univ Cincinnati, Coll Med, Vet Affairs Med Ctr, Dept Pathol, Cincinnati, OH 45220 USA
[3] Childrens Med Ctr, Cincinnati, OH 45220 USA
[4] Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA
关键词
D O I
10.4049/jimmunol.170.9.4818
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mechanisms that initiate lupus nephritis and cause progression to end-stage renal disease remain poorly understood. In this study, we show that lupus-prone New Zealand Mixed 2410 mice that develop a severe glomerulosclerosis and rapidly progressive renal disease overexpress IL-4 in vivo. In these mice, STAT6 deficiency or anti-IL-4 Ab treatment decreases type 2 cytokine responses and ameliorates kidney disease, particularly glomerulosclerosis, despite the presence of high levels of IgG anti-dsDNA Abs. STAT4 deficiency, however, decreases type 1 and increases type 2 cytokine responses, and accelerates nephritis, in the absence of high levels of IgG anti-dsDNA Abs. Thus, STAT6 and IL-4 may selectively contribute to the development of glomerulosclerosis, whereas STAT4 may play a role in autoantibody production.
引用
收藏
页码:4818 / 4825
页数:8
相关论文
共 47 条
[1]   Genetic regulation of commitment to interleukin 4 production by a CD4+ T cell-intrinsic mechanism [J].
Bix, M ;
Wang, ZE ;
Thiel, B ;
Schork, NJ ;
Locksley, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2289-2299
[2]   THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
LEBMAN, DA ;
HIRAKI, DD ;
CHRISTIANSEN, JA ;
SHRADER, B ;
CHERWINSKI, HM ;
SAVELKOUL, HFJ ;
FINKELMAN, FD ;
BOND, MW ;
MOSMANN, TR .
IMMUNOLOGICAL REVIEWS, 1988, 102 :5-28
[3]   Advances in immunology - Autoimmune diseases [J].
Davidson, A ;
Diamond, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (05) :340-350
[4]   Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice [J].
Erb, KJ ;
Ruger, B ;
vonBrevern, M ;
Ryffel, B ;
Schimpl, A ;
Rivett, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (02) :329-339
[5]   Vaccination with minigenes encoding VH-derived major histo compatibility complex class I-binding Epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus [J].
Fan, GC ;
Singh, RR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :731-741
[6]   Development of an assay to measure in vivo cytokine production in the mouse [J].
Finkelman, FD ;
Morris, SC .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (11) :1811-1818
[7]  
Funauchi M, 1998, SCAND J RHEUMATOL, V27, P219
[8]   INTERLEUKIN-4 STIMULATES COLLAGEN GENE-EXPRESSION IN HUMAN FIBROBLAST MONOLAYER-CULTURES - POTENTIAL ROLE IN FIBROSIS [J].
GILLERY, P ;
FERTIN, C ;
NICOLAS, JF ;
CHASTANG, F ;
KALIS, B ;
BANCHEREAU, J ;
MAQUART, FX .
FEBS LETTERS, 1992, 302 (03) :231-234
[9]  
ILLERA VA, 1993, J IMMUNOL, V151, P2965
[10]   INTERLEUKIN-12 SIGNALING IN T-HELPER TYPE-1 (TH1) CELLS INVOLVES TYROSINE PHOSPHORYLATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT)3 AND STAT4 [J].
JACOBSON, NG ;
SZABO, SJ ;
WEBERNORDT, RM ;
ZHONG, Z ;
SCHREIBER, RD ;
DARNELL, JE ;
MURPHY, KM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1755-1762